Squarepoint
TELA icon

Squarepoint’s TELA Bio TELA Stock Holding History

Squarepoint’s Portfolio TELA Stock Details TELA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-13,422
Closed -$34K – 5491
2024
Q3 		$34K Sell
13,422
-14,606
-52% -$52K ﹤0.01% 4001
2024
Q2 		$132K Buy
+28,028
New +$148K ﹤0.01% 3747
2024
Q1 		– Sell
-37,931
Closed -$251K – 4610
2023
Q4 		$251K Buy
+37,931
New +$219K ﹤0.01% 3466
2021
Q1 		– Sell
-27,100
Closed -$408K – 3607
2020
Q4 		$408K Sell
27,100
-10,054
-27% -$163K ﹤0.01% 1962
2020
Q3 		$615K Buy
+37,154
New +$522K 0.01% 1278

Other funds holding TELA

EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return

Squarepoint's TELA Position: Q4 2024 in Review

Squarepoint sold out of TELA Bio (TELA) in Q4 2024, closing a stake of 13,422 shares — an estimated $34K sold.

Squarepoint first reported a position in TELA in Q3 2020 and held it in 5 quarters. The position peaked at $615K in Q3 2020. 47 funds tracked by Wall St. Rank hold TELA as of Q4 2024.

  • Squarepoint reported no remaining TELA Bio position as of Q4 2024 after selling out during the quarter.
  • Squarepoint sold 13,422 TELA Bio shares in Q4 2024, an estimated $34K.
  • Squarepoint first reported a position in TELA Bio in Q3 2020 and held it in 5 quarters.
  • Squarepoint's TELA Bio position peaked at $615K in Q3 2020.
  • 47 funds tracked by Wall St. Rank held TELA Bio as of Q4 2024.

Based on Squarepoint's 13F filing for Q4 2024, filed 14 Feb 2025.